Quanterix

Akoya Biosciences is a spatial biology company offering the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and autoimmune or neurological disorders. The CODEX system is the only benchtop platform that can efficiently quantify more than 40 biomarkers and is ideally suited for biomarker discovery. The Phenoptics platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials.

Emission Inc. specializes in manufacturing cytometry instruments and reagents for measuring fluorescence in bead-based biological assays. Their product range includes dye-encapsulating magnetic beads suitable for low and mid-plex assays, and a mid-plex platform designed to read these proprietary beads. The company's mission is to make multiplex assays more accessible and affordable by offering higher-performance instruments and reagents.

UmanDiagnostics specializes in providing neurofilament light (Nf-L) antibodies and ELISA kits aimed at enhancing the diagnosis and treatment of neurodegenerative diseases. The company develops biopharmaceutical products that facilitate the accurate measurement of neurofilament light in cerebrospinal fluid, enabling healthcare professionals to quickly and effectively assess various neurological conditions and traumatic brain injuries. By offering innovative diagnostic tools, UmanDiagnostics contributes to the advancement of therapeutics and diagnostics in the field of neurology, improving the ability to detect and manage neurological disorders.